Search clinical trials for: PIK3CA analysis

Total 6246 results

Fondazione Policlinico Universitario Agostino Gemelli...

Active, not recruiting

PIK3CA in HER2+ BC and pCR Trial

HER2-positive Breast Cancer

Italy
Pharmassist Ltd
University of Athens

Active, not recruiting

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC

Breast Cancer

Greece
Centre Hospitalier Universitaire Dijon

Recruiting

Study of Locomotor Expectations for Ascending/Descending Slope and Stairs in Patients With Limb Amputations (JCE)

Lower Limb Amputation

France
GWT-TUD GmbH

Terminated

Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY (SAMBA)

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

France, Germany
Medwave Estudios Limitada
Asociación Chilena de Seguridad

Unknown

Diagnostic Value of Workload Analysis Instrument to Detect Occupational Risks of Upper Limb Musculoskeletal Conditions (ACT-ACHS)

Occupational Exposure | Musculoskeletal Disease

Chile
Medical University of Warsaw

Completed

Short and Long-term Results of Arterial Stiffness and Central Aortic Pressure After Kidney Transplantation (PWV/CP/KTx)

Arterial Calcification | Aortic Stiffness | High Blood Pressure (& [Essential Hypertension])

Poland
Institute of Oncology Ljubljana

Active, not recruiting

Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients

Melanoma | PET CT

Slovenia
Assistance Publique - Hôpitaux de Paris

Completed

Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN (EU-TRAIN)

Kidney Transplantation | Kidney Transplant Rejection | Prognosis | Risk Stratification

France, Germany, Spain, Switzerland
Yisheng Biopharma (Singapore) Pte. Ltd.
Duke-NUS Graduate Medical School

Completed

Safety and Efficacy of a PIKA Rabies Vaccine Containing the PIKA Adjuvant

Rabies

Singapore
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030

Lung Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma

Sarcoma
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia

Leukemia
Oxford University Hospitals NHS Trust

Unknown

Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

Myelodysplastic Syndromes | Leukemia

United Kingdom
National Cancer Institute (NCI)

Unknown

Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment

Leukemia
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia

Leukemia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia

Leukemia
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck

Head and Neck Cancer

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Study of Bone Marrow Samples From Patients With Acute Leukemia

Leukemia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Young Patients With Neuroblastoma

Neuroblastoma
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer

Kidney Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer

Sarcoma | Kidney Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Liver Cancer | Pleuropulmonary Blastoma | Hereditary Wilms Tumor
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia

Leukemia

Australia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Leukemia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Samples From Young Patients With Soft Tissue Sarcoma

Sarcoma
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia

Leukemia
AIDS Malignancy Consortium
National Cancer Institute (NCI); The Emmes Company, LLC

Terminated

Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy

Lymphoma | Nonneoplastic Condition

United States
Cancer Research UK

Unknown

Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer

Gastric Cancer | Esophageal Cancer | Adenocarcinoma of the Gastroesophageal Junction

United Kingdom
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia

Leukemia

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Gene Expression in Samples From Patients With Rhabdoid Tumors

Kidney Cancer | Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001

Gastrointestinal Stromal Tumor

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia

Leukemia
Duke University
National Cancer Institute (NCI)

Completed

Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor

Lymphoma | Brain and Central Nervous System Tumors

United States
Queen Mary University of London

Unknown

Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers

Breast Cancer

United Kingdom
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia

Leukemia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia

Leukemia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma

Neuroblastoma
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Genes in Samples From Younger Patients With Adrenocortical Tumor

Adrenocortical Carcinoma
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia

Leukemia
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia

Leukemia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Biomarkers in Samples From Patients With Rhabdomyosarcoma

Sarcoma
The Christie NHS Foundation Trust

Unknown

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Sarcoma | Cervical Cancer | Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Prostate Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Primary Peritoneal Cavity Cancer

United Kingdom
Institut du Cancer de Montpellier - Val d'Aurelle

Unknown

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

Colorectal Cancer | Esophageal Cancer

France
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Unknown

Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia

Leukemia
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia

Leukemia

United States
Cancer Research UK

Unknown

Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends

Breast Cancer

United Kingdom
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx

Head and Neck Cancer
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Gene Expression and Location in Samples From Patients With Brain Tumors

Brain and Central Nervous System Tumors
Gynecologic Oncology Group
National Cancer Institute (NCI)

Unknown

Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer
KU Leuven

Not yet recruiting

Molecular Assessment for Gastro-Esophageal Cancer (MAGEC)

Gastric Cancer | Esophageal Cancer | Barrett Esophagus

Search clinical trials for: PIK3CA analysis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations